Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2024 (1)
  • 2022 (4)

Subject

  • Drug Trafficking (224)
  • Synthetic drugs (214)
  • Fake Pills (195)
  • Guns/Weapons (72)
  • Seizures (Drugs/Property) (51)
  • OCDETF/Task Force (43)
  • Guilty Plea (27)
  • Overdose (13)
  • Arrests/Convictions - Major (9)
  • Gangs (9)
  • Money Laundering (8)
  • Fentanyl Awareness (5)
  • HIDTA (5)
  • Major Law Enforcement Operation (5)
  • Press Conferences (5)
  • Diversion Division (4)
  • One Pill Can Kill (3)
  • Prescription Drugs (3)
  • Extraditions (2)
  • Pharmaceuticals/Pharmacists/Physicians (2)
  • Dark Web- Internet Trafficking (1)
  • Fentanyl Free America (1)
  • Prevention/Education - DEA websites GSAD, JTT etc (1)
  • Take Back Day (1)
  • Task Forces/Task Force Officers (1)
  • Outreach/Drug Prevention (5)

Drug Name

  • Fentanyl (5)

Field Division

  • Washington, DC (14)
  • Sede (7)
  • Rocky Mountain (6)
  • Omaha (4)
  • St. Louis (4)
  • Miami (3)
  • El Paso (2)
  • New England (2)
  • Atlanta (1)
  • Dallas (1)
  • Houston (1)
  • New Orleans (1)
  • Phoenix (1)
  • San Diego (1)
  • Seattle (5)
Clear All Results
PRESS RELEASE

This Holiday Season Talk to Your Loved Ones About Fentanyl

Diciembre 19, 2024
SEATTLE- This holiday season, full of travel and family gatherings, the Drug Enforcement Administration (DEA) Seattle Division is urging communities across the Pacific Northwest to make the most of this time together by having conversations about the dangers of fentanyl. Fentanyl is the deadliest drug threat our nation has ever...
Diciembre 19, 2024
PRESS RELEASE

DEA Seattle Field Division Joins with Families to Increase Awareness about the Dangers of Fentanyl

Noviembre 21, 2022
SEATTLE– This week the Drug Enforcement Administration (DEA) hosted regional family summits across the country in support of those who have lost loved ones to fentanyl poisoning. The DEA Seattle Field Division invited families from Washington, Oregon, Alaska and Idaho to the Family Summit held in Seattle on November 15th...
Noviembre 21, 2022
PRESS RELEASE

Federal Law Enforcement Officials Warn of "Rainbow Fentanyl" Appearing in Oregon

Agosto 30, 2022
PORTLAND, Ore.—With at least two notable seizures in the last several days in the Portland Metropolitan Area, officials from the U.S. Attorney’s Office for the District of Oregon and U.S. Drug Enforcement Administration are warning Oregonians to be on the lookout for “rainbow fentanyl,” a brightly-colored version of the highly-toxic...
Agosto 30, 2022
PRESS RELEASE

DEA Recognizes First Ever National Fentanyl Awareness Day

Mayo 10, 2022
SEATTLE– In an effort to save lives, DEA is proud to join “Song for Charlie” and many of our valued public health, non-profit, and law enforcement partners in recognizing the first ever National Fentanyl Awareness Day. This day is an effort to educate individuals around the dangerous threat that fentanyl...
Mayo 10, 2022
PRESS RELEASE

DEA Launches Operation Engage Spokane to Target Fentanyl

Marzo 29, 2022
SPOKANE, Wash.–The United States Drug Enforcement Administration is launching Operation Engage in Spokane, Washington. Operation Engage Spokane is a comprehensive community-level approach to address the drug epidemic through prevention strategies, facilitating conversations and collaboration with local partners. The Seattle Field Division’s proposal was one of 11 approved for continued funding...
Marzo 29, 2022
Showing 1 - 5 of 5 results
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster